Novonesis (Novozymes) B
(FRA:NZM2)
€
57.2
-0.14 (-0.24%)
Market Cap: 26.58 Bil
Enterprise Value: 28.31 Bil
PE Ratio: 39.62
PB Ratio: 2.44
GF Score: 95/100 Novozymes A/S Spotlight on Human Health Presentation Transcript
Jun 17, 2022 / 12:00PM GMT
Release Date Price:
€54.32
(-0.77%)
Operator
Presentation
Jun 17, 2022 / 12:00PM GMT
=====================
Corporate Participants
=====================
* Ulrich Irgens
=====================
Conference Call Participants
=====================
* Alexander Jones
BofA Securities, Research Division - Analyst
* André Thormann
Danske Bank A/S, Research Division - Analyst
* Lars Topholm
Carnegie Investment Bank AB, Research Division - Co-Head of Research of Denmark & Financial Analyst
=====================
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot